CB29253-5 - 0x0000000000004A4E

Healthy Males & Females

* Stipend may pay up to reflected amount.
Start Date: 
February 28, 2021 - 10:15am
End Date: 
March 12, 2021 - 2:15pm

Study Details

Study Number: CB29253
Group Number: 5
Study Requirement: Healthy Normal Male and Female
Stipend: up to £ No search results

Study Criteria

Age: 18 - 50
BMI: 19 - 29.9
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat cough associated with COVID-19.
Route of Administration: Inhalation
Blood Draws: 0

Study Schedule

Schedule Type: Long Term
Study Length: One - 8 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date Site
No search results

Doctor Exam Dates:

Event Day Event Date Site
No search results

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday Feb 28 2021 10:15AM Monday Mar 8 2021 12:00PM 1 Belfast
Phone participant Friday Mar 12 2021 2:15PM 1 Belfast